Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivo Bio Tech has postponed its Board meeting originally scheduled for May 29, 2026 to May 30, 2026. The meeting agenda includes approval of audited standalone and consolidated financial results for Q4 and full year ended March 31, 2026. More significantly, the board will consider and approve a proposed amalgamation of Shri Shri Resorts Private Limited (Transferor Company) into Vivo Bio Tech Limited (Transferee Company) under Sections 230-232 of the Companies Act, 2013. The trading window for insiders remains closed until June 1, 2026.
The proposed amalgamation, if approved, would expand Vivo Bio Tech's operations through merger with Shri Shri Resorts Private Limited. This corporate restructuring under the NCLT scheme process could be positive for shareholders pending final approval and regulatory clearances.